Humana Inc. to Issue Quarterly Dividend of $0.89 (NYSE:HUM)

Humana Inc. (NYSE:HUM - Get Free Report) declared a quarterly dividend on Thursday, February 20th, RTT News reports. Investors of record on Friday, March 28th will be paid a dividend of 0.885 per share by the insurance provider on Friday, April 25th. This represents a $3.54 dividend on an annualized basis and a yield of 1.38%. The ex-dividend date is Friday, March 28th.

Humana has increased its dividend payment by an average of 8.1% annually over the last three years. Humana has a dividend payout ratio of 25.4% indicating that its dividend is sufficiently covered by earnings. Equities analysts expect Humana to earn $13.13 per share next year, which means the company should continue to be able to cover its $3.54 annual dividend with an expected future payout ratio of 27.0%.

Humana Trading Down 5.7 %

NYSE:HUM traded down $15.53 during trading hours on Friday, reaching $255.77. The company's stock had a trading volume of 2,862,870 shares, compared to its average volume of 1,707,253. The firm has a market capitalization of $30.80 billion, a price-to-earnings ratio of 25.71, a PEG ratio of 2.00 and a beta of 0.56. The firm has a 50-day simple moving average of $269.41 and a 200-day simple moving average of $290.45. Humana has a 1 year low of $213.31 and a 1 year high of $406.46. The company has a debt-to-equity ratio of 0.68, a quick ratio of 1.76 and a current ratio of 1.76.

Humana (NYSE:HUM - Get Free Report) last issued its earnings results on Tuesday, February 11th. The insurance provider reported ($2.16) EPS for the quarter, topping analysts' consensus estimates of ($2.26) by $0.10. Humana had a net margin of 1.02% and a return on equity of 11.70%. Research analysts expect that Humana will post 16.47 EPS for the current fiscal year.

Analysts Set New Price Targets

A number of equities analysts have issued reports on the stock. Bank of America upgraded shares of Humana from an "underperform" rating to a "neutral" rating and boosted their price objective for the company from $247.00 to $308.00 in a research report on Wednesday, November 6th. TD Cowen boosted their price objective on shares of Humana from $261.00 to $268.00 and gave the company a "hold" rating in a research report on Monday, November 4th. Piper Sandler boosted their price objective on shares of Humana from $270.00 to $288.00 and gave the company a "neutral" rating in a research report on Wednesday, January 15th. JPMorgan Chase & Co. decreased their price objective on shares of Humana from $257.00 to $256.00 and set a "neutral" rating on the stock in a research report on Tuesday. Finally, Royal Bank of Canada restated an "outperform" rating and issued a $283.00 price objective on shares of Humana in a research report on Wednesday, February 12th. Nineteen investment analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. According to data from MarketBeat.com, the company presently has an average rating of "Hold" and a consensus target price of $285.68.

Insider Buying and Selling

In related news, insider Timothy S. Huval sold 3,703 shares of the business's stock in a transaction dated Tuesday, December 31st. The shares were sold at an average price of $256.26, for a total transaction of $948,930.78. Following the sale, the insider now owns 8,181 shares of the company's stock, valued at $2,096,463.06. The trade was a 31.16 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. 0.32% of the stock is currently owned by insiders.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.